ZA975902B - Topical composition - Google Patents

Topical composition

Info

Publication number
ZA975902B
ZA975902B ZA975902A ZA975902A ZA975902B ZA 975902 B ZA975902 B ZA 975902B ZA 975902 A ZA975902 A ZA 975902A ZA 975902 A ZA975902 A ZA 975902A ZA 975902 B ZA975902 B ZA 975902B
Authority
ZA
South Africa
Prior art keywords
topical composition
topical
composition
Prior art date
Application number
ZA975902A
Inventor
Werner Tschollar
Beat Schmid
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Publication of ZA975902B publication Critical patent/ZA975902B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
ZA975902A 1996-07-02 1997-07-02 Topical composition ZA975902B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96810436 1996-07-02

Publications (1)

Publication Number Publication Date
ZA975902B true ZA975902B (en) 1999-01-04

Family

ID=8225640

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA975902A ZA975902B (en) 1996-07-02 1997-07-02 Topical composition

Country Status (7)

Country Link
EP (1) EP0910410A1 (en)
JP (1) JP2000515498A (en)
AU (1) AU3440697A (en)
CA (1) CA2258513A1 (en)
TR (1) TR199802769T2 (en)
WO (1) WO1998000168A1 (en)
ZA (1) ZA975902B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1073738B1 (en) * 1998-04-21 2004-09-29 Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. Human k+ ion channel and therapeutic applications thereof
AU4972599A (en) * 1998-07-07 2000-01-24 Transdermal Technologies, Inc. Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
US6284802B1 (en) 1999-04-19 2001-09-04 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue
EP1050300B1 (en) 1999-04-22 2004-08-04 Shiseido Company Limited Selective antibacterial composition
DE60137569D1 (en) * 2000-05-09 2009-03-19 Unilever Nv PULEGON CONTAINING COSMETIC SKIN CARE COMPOSITIONS
AU2002229611A1 (en) * 2000-12-08 2002-06-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells
WO2002096870A2 (en) * 2001-05-31 2002-12-05 The Regents Of The University Of California Sponge-derived terpenoids and methods of use
US6720423B2 (en) 2002-04-30 2004-04-13 Allergan, Inc. Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
JP4614638B2 (en) * 2002-06-07 2011-01-19 第一三共株式会社 Analgesic composition
WO2004110396A1 (en) * 2003-06-17 2004-12-23 Dsm Ip Assets B.V. Topical agents containing phytanic acid or a derivative thereof
GB0417909D0 (en) * 2004-08-11 2004-09-15 Novartis Consumer Health Sa Drop preparations
US7288263B2 (en) * 2004-09-13 2007-10-30 Evera Laboratories, Llc Compositions and methods for treatment of skin discoloration
WO2007046544A1 (en) * 2005-10-21 2007-04-26 Medrx Co., Ltd. Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine
WO2007110380A1 (en) * 2006-03-25 2007-10-04 Boehringer Ingelheim International Gmbh Insect bite relief preparation comprising epinastine
US20090136430A1 (en) * 2007-11-27 2009-05-28 Dugger Harry A Antihistamine/Corticosteroid preparations for the treatment of atopic dermatitis
CN101390830B (en) * 2008-11-12 2011-05-18 常州市第四制药厂有限公司 Anarexol cream and preparation method thereof
JP5912238B2 (en) * 2010-09-30 2016-04-27 小林製薬株式会社 Emulsified composition
ES2598753T3 (en) 2012-11-27 2017-01-30 Eduardo Cos Alfonso Pharmaceutical composition for the treatment of calcified tendinitis and / or calcified bursitis
JP6552414B2 (en) * 2013-02-01 2019-07-31 ディードロップス カンパニー Liquid menthol composition
JP6537775B2 (en) * 2014-03-10 2019-07-03 小林製薬株式会社 Emulsified composition
WO2018063876A1 (en) * 2016-09-30 2018-04-05 Alpha To Omega Pharmaceutical Consultants, Inc. Transdermal and/or topical delivery systems comprising cetirizine dihydrochloride

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59122420A (en) * 1982-12-28 1984-07-14 Otsuka Pharmaceut Factory Inc Local ointment
DE3579343D1 (en) * 1984-03-07 1990-10-04 Roshdy Ismail AGENTS FOR TREATING AND PROTECTING THE SKIN.
JPS62205019A (en) * 1986-03-03 1987-09-09 Kao Corp Drug for external use
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
WO1989012626A1 (en) * 1988-06-24 1989-12-28 Stephen Herman Ozonides of terpenes and their medical uses
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
JPH04154719A (en) * 1990-10-19 1992-05-27 Hiroshi Kikuchi Athlete's foot drug
WO1992013540A1 (en) * 1991-02-06 1992-08-20 Guy Parent Antalgic ointment
JPH05286860A (en) * 1992-04-03 1993-11-02 Kowa Co Gel ointment
AU5134893A (en) * 1992-10-09 1994-05-09 Procter & Gamble Company, The Anaesthetic compositions

Also Published As

Publication number Publication date
JP2000515498A (en) 2000-11-21
EP0910410A1 (en) 1999-04-28
CA2258513A1 (en) 1998-01-08
WO1998000168A1 (en) 1998-01-08
AU3440697A (en) 1998-01-21
TR199802769T2 (en) 1999-04-21

Similar Documents

Publication Publication Date Title
CY2506B1 (en) Composition
GB9624874D0 (en) Composition
HK1034663A1 (en) Topical compositions comprising ascorbyl-phosphoryl-cholesterol
GB9601398D0 (en) Composition
GB9612595D0 (en) Composition
ZA975902B (en) Topical composition
GB9605247D0 (en) Composition
EP0884044A4 (en) Hairtreatment composition
ZA974266B (en) Anti-vaginitis compositions for topical use
GB9619074D0 (en) Composition
GB9600604D0 (en) Composition
GB9602266D0 (en) Composition
AU2310395A (en) Topical retinal-based composition
ZA974126B (en) Topical composition
GB9606901D0 (en) Topical composition
GB9610966D0 (en) Composition
ZA97698B (en) Composition
PL330421A1 (en) Antiprespirant composition
GB9410139D0 (en) Hebicidal composition
GB9604585D0 (en) Composition
GB9612417D0 (en) A topical composition
GB9506040D0 (en) Topical composition
GB9602811D0 (en) Composition
GB9613644D0 (en) Composition
GB9625040D0 (en) Composition